ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2286

Mobile Responsive App – Useful Additional Tool for Data Collection in the German Pregnancy Register Rhekiss?

Jutta Richter1, Christina Bungartz 2, Anja Weiß 3, Rebecca Fischer-Betz 4, Angela Zink 5, Matthias Schneider 1 and Anja Strangfeld 3, 1Department and Hiller Research Unit of Rheumatology, Heinrich-Heine University Duesseldorf, Duesseldorf, Nordrhein-Westfalen, Germany, 2German Rheumatism Research Center (DRFZ), Berlin, Berlin, Germany, 3German Rheumatism Research Center (DRFZ), Berlin, Germany, 4Policlinic for Rheumatology & Hiller Research Centre for Rheumatology, Heinrich-Heine-University Duesseldorf, Düsseldorf, Germany, 5German Rheumatism Research Centre and Charité University medicine, Berlin, Germany

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: pregnancy and digital technologies, registry

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 12, 2019

Title: Reproductive Issues In Rheumatic Disorders Poster

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: The German pregnancy register Rhekiss is designed as a nationwide, web-based longitudinal observational register established in 2015. The register follows women with inflammatory rheumatic disease prospectively from child wish through pregnancy until two years postpartum. During the observation, information on clinical and laboratory parameters, disease activity, comorbidities, flares, drug treatment, and (adverse) pregnancy outcomes are documented in pre-specified intervals. Physicians and patients (pts) report data for the same time periods via separated accounts and questionnaires (Qs) into a web-based application on personal computers, laptops, and notebooks. Due to the increasing use of mobile devices, a responsive App as a further documentation option and for facilitated patient-reported data entry was developed. We examined whether pts use an App for data entry in the pregnancy register.

Methods: The Rhekiss-App is available in German and can be downloaded for self-reported data retrieval since 08/2017 from App stores (Android and iOS). For the current analysis, Rhekiss register data were used from the time period October 2018 until April 2019 to ensure valid data on the applications modes.

Results: Within the analyzed period Rhekiss expected answers from 2207 Qs of 889 pts. Overall, 71.2% of the Qs were filled in. 49.9% of the Qs were sent from a browser installed on a desktop computer, ranging from 56% (January 2019) to 46% (April 2019), see table 1. Desktop users were on average 34±3.8 years old; the proportion of desktop users was highest in women after delivery (52%). The App installed on mobile devices was used for data entry of 760 Qs (50.1%): Smartphone use ranged between 37% and 49%, tablet use was less frequent (up to 9%), and phablet use was neglectable, see table 1. Women with child wish had the highest smartphone App use (51%). Figure 1 depicts the progress of desktop and mobile documented Qs.

Conclusion: The responsive App is a useful additional tool for data collection in Rhekiss. It was used for data acquisition from approximately 50% of the questionnaires. While the use of the App on a smartphone was of high interest, the use of tablets/phablets for data collection seems negligible. Apart from desktop/browser developments, technological adoptions within observational cohorts and/or future (joined) registries need to take smartphone requirements and developments into account, especially when patient-reported data in young, mobile patients are collected.

 Acknowledgement: The register’s mobile App was implemented with software development from the IT partners Serrala, Berlin (Germany) and Questback, Köln (Germany)

Figure 1 Progress of desktop and mobile documented questionnaires

Table 1 Utilization of the various documentation routes over time


Disclosure: J. Richter, None; C. Bungartz, None; A. Weiß, None; R. Fischer-Betz, None; A. Zink, Astra Zeneca, BMS, Lilly, Pfizer, Roche und UCB, 5, 8; M. Schneider, None; A. Strangfeld, AbbVie, BMS, MSD, Pfizer, Roche, Takeda and UCB, 8.

To cite this abstract in AMA style:

Richter J, Bungartz C, Weiß A, Fischer-Betz R, Zink A, Schneider M, Strangfeld A. Mobile Responsive App – Useful Additional Tool for Data Collection in the German Pregnancy Register Rhekiss? [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/mobile-responsive-app-useful-additional-tool-for-data-collection-in-the-german-pregnancy-register-rhekiss/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/mobile-responsive-app-useful-additional-tool-for-data-collection-in-the-german-pregnancy-register-rhekiss/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology